Pro-endothelin-1 for the prediction of impaired peak oxygen consumption

A technique for endothelin, peak, in the field of proendothelin 1 for prediction of impaired peak oxygen consumption

Inactive Publication Date: 2017-11-28
BRAHMS GMBH
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Similar studies in less selected patient groups and studies using other biomarkers are not yet available

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
  • Pro-endothelin-1 for the prediction of impaired peak oxygen consumption
  • Pro-endothelin-1 for the prediction of impaired peak oxygen consumption

Examples

Experimental program
Comparison scheme
Effect test

Embodiment

[0052] overview

[0053] The present study of representative samples of unselected patients recommended for CPET revealed two important findings: first, the correlation between CT-proET-1 measured at rest and peak VO 2 correlated, and are severely impaired at peak VO 2 outperforms BNP due to its high accuracy in the prediction of . Second, additional measurements of CT-proET-1 and BNP resulted in WL max Used to predict severely impaired peak VO 2 accuracy increased significantly.

[0054] method

[0055] research group

[0056] From May 2004 to June 2005, 185 consecutive patients recommended for CPET to assess unexplained exercise intolerance were eligible for enrollment. We excluded patients without informed consent (n = 12) and patients without CT-pro-ET-1 and / or BNP measurements (n = 11). This leaves a total of 162 patients for this analysis. This study was approved by the local ethics committee. Written informed consent was obtained from all participating patien...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Subject of the present invention is an in vitro method for the alternative assessment of peak oxygen consumption (VO2) for a subject not having a heart failure by measuring Pro-Endothelin-1 (ProET-1) or fragments thereof.

Description

[0001] This application has an international application date of April 8, 2009, international application number PCT / EP2009 / 054251 entered the Chinese national phase on November 26, 2010, application number 200980119411.X, and the title of the invention "For predicting damaged peak oxygen consumption Amount of proendothelin 1" divisional application. technical field [0002] The subject of the present invention is a method for predicting impaired peak oxygen consumption (VO2) in subjects without heart failure. 2 ) in vitro method: [0003] Determining the level of proendothelin 1 (ProET-1) or a fragment thereof of at least 12 amino acids in a sample obtained from said subject; [0004] Use stated levels of proendothelin 1 (ProET-1) or fragments thereof of at least 12 amino acids as peak VO 2 surrogate markers. [0005] Another subject of the invention is the use of this method for risk assessment prior to non-cardiac surgery. Background technique [0006] Maximal Cardiop...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): G01N33/68
CPCG01N33/6857G01N33/6893G01N2333/5754G01N2800/32
Inventor 约阿希姆·斯特鲁克尼尔斯·莫根塔勒安德烈亚斯·贝格曼克里斯蒂安·穆勒
Owner BRAHMS GMBH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap